The Role of Fibroblast Growth Factors in Tumor Growth
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
639-651
Author(s):
M. Korc and R. E. Friesel
Fluorescent Cisplatin Analogues and Cytotoxic Activity
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4314-4327
Author(s):
E. Rodriguez-Fernandez, J. L. Manzano, A. Alonso, M J. Almendral, M. Perez-Andres, A. Orfao and J. J. Criado
The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4544-4580
Author(s):
E. Gabano, M. Ravera and D. Osella
Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
92-102
Author(s):
Ahmed M. Ragheb and Edmund S. Sabanegh Jr.
Tubulin-Targeting Agents in Hybrid Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
609-639
Author(s):
E. C. Breen and J. J. Walsh
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
324-337
Author(s):
Chiara Gabbiani, Francesca Magherini, Alessandra Modesti and Luigi Messori
Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
725-733
Author(s):
Cecilia Menna, Fabiola Olivieri, Alfonso Catalano and Antonio Procopio
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
312-323
Author(s):
Denise de Oliveira Silva
Future Prospect of RNA Interference for Cancer Therapies
Journal:
Current Drug Targets
Volume:
11
Page:
345-360
Author(s):
Eishi Ashihara, Eri Kawata and Taira Maekawa
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1813-1825
Author(s):
Michael Frezza, Sarmad Hindo, Di Chen, Andrew Davenport, Sara Schmitt, Dajena Tomco and Q. Ping Dou